Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017

Gena Wang Initiated (BLUE) at Buy and Held Target at $151 on, Sep 7th, 2017

Gena Wang of Barclays, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $151 on, Sep 7th, 2017.

Gena has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 4 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Initiated at Hold and Held Target at $102 on, Thursday, August 17th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $105 on, Monday, August 7th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017
  • Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017


This is the rating of the analyst that currently disagrees with Gena


  • Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017